Twitxy Saved

KathleenCorey

@KathleenCoreyMD

Hepatologist and Associate Professor at Harvard Medical School translating the science and human side of MASLD, clinical trials, academic medicine.
Boston, MA mghnafld.com Joined May 2026
982 Following 214 Followers 875 Posts

Latest posts 5

KathleenCorey @KathleenCoreyMD
My amazing sister Kristin Corey developed a protein score for MACE which is, amazingly, modifiable. What an accomplishment!
Svati Shah @SvatiShah Sep 2
So proud of Kristin Corey, an incredible pulmonary fellow @DukeMedSchool who led this great work! A protein score that predicts MACE and is modifiable by GLP-1 RA @LiJenniferS @kcooney1234 @pamelasdouglas @robmentz @texhern @RobGersztenMD
View quoted post on X
1 replies 1 reposts 10 likes 1.5K views View on X
KathleenCorey @KathleenCoreyMD
Delighted to speak at the @alehlatam @AASLDtweets Congress in CDMX on how the Hepatologist can help cardiometabolic health.
1. Chose therapy wisely - semaglutide also approved for secondary CVD prevention while tirzepatide for primary prevention in high-risk patients.
2. Help risk stratify (CPR & PREVENT) patients & encourage lipid lowering therapy (LLT)
3. Resmetirom has a uniquely positive lipid profile lowering LDL & apoB,
good choice for dyslipidemia plus LLT
2 replies 5 reposts 17 likes 956 views View on X
KathleenCorey @KathleenCoreyMD
New, exciting work to determine frailty, and associated mortality in cirrhosis!
Jen Lai @JenLaiLiverDoc Aug 28
Introducing the Cirrhosis Administrative Frailty Index (CAFI), the first claims-based frailty index developed for cirrhosis, validated against the in-person LFI.

Check out this work led by brilliant surgeon Dr. Lucia Calthorpe. doi.org/10.1097/LVT.00…
View quoted post on X